Skip to content
WeighLab
Provider review

T2D.com Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

T2D.com is a type-2-diabetes and prediabetes telehealth service that also sells compounded semaglutide or tirzepatide with its own prescriber for $170 a month all-in.

In this review

Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.

Check T2D.com prices Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.

Prices at a glance

Semaglutide
$170/moPrescriber and medication included, month-to-month, compounded
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Not confirmed

Semaglutide · estimated annual cost

$2,040

Who T2D.com may suit

Shoppers who want one monthly fee covering the prescriber and compounded semaglutide, or who already hold an outside prescription.

Where the value is

  • $170/mo covers the prescriber, the medication, delivery and ongoing support
  • A $99/mo semaglutide rate if you already have a prescription from your own doctor
  • No contract; cancel any time from your account
  • Offers both compounded semaglutide and compounded tirzepatide

The tradeoffs

  • No tirzepatide price is published, though tirzepatide is offered
  • No state list is published, so you can't check eligibility before signing up
  • No named compounding pharmacy, medical director or LegitScript certification
  • No refund for any part of a month you've already paid for
  • Built mainly as a diabetes-care brand, with weight loss as a second program

What T2D sells, and how it's priced

T2D started as a medication service for people with type 2 diabetes and prediabetes, and it still presents itself that way. Its newer offering, which it calls a "complete service," bundles a licensed prescriber with compounded semaglutide or compounded tirzepatide in one monthly subscription. The medication is part of the fee, not a separate purchase.

With T2D's own prescriber, the program is $170 a month, all-inclusive, with no contract. If you already have a prescription from your own doctor, T2D will fill compounded semaglutide at the 0.25 mg or 0.50 mg dose for $99 a month instead. T2D doesn't publish a separate tirzepatide price, so ask what it costs, and whether the fee changes as your dose goes up, before you enter a card.

The subscription is charged on the day you sign up and again on the same day each month. T2D doesn't take insurance.

Considering T2D.com?

Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.

What the complete service includes

  • A licensed prescriber who evaluates you and chooses the medication and dose. T2D says no separate telehealth appointment is needed.
  • Your compounded semaglutide or tirzepatide, prepared by T2D's pharmacy partners.
  • Delivery by UPS or FedEx in temperature-controlled packaging.
  • Ongoing check-ins and refills as needed.

T2D doesn't name its prescribers or its pharmacies. It describes its pharmacy partners as vetted and licensed and says they coordinate with the prescriber directly. Ask which pharmacy will fill your order before you start.

Who's behind it

T2D is owned by Vertical Insight Corp. Its founders come from health insurance and software, and former NFL linebacker Alec Ogletree is a co-founder. The company's stated view is that a primary care doctor or specialist should ideally manage your medication. If you already have one, ask whether your doctor can coordinate with T2D's prescriber.

Canceling

You can cancel from your account or by emailing support at any time. Your access runs to the end of the month you've paid for, and T2D's terms are blunt that there's no refund for any part of the current subscription period. Cancel before your monthly renewal date if you're stopping.

Before you sign up

  • T2D doesn't publish a list of the states it serves. Confirm yours during registration.
  • Compounded semaglutide and tirzepatide aren't FDA-approved, and T2D doesn't offer brand-name Wegovy or Zepbound.

The Index scorecard

T2D.com scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month66/100
Price Transparency86/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight69/100
Contract Flexibility55/100

The bottom line

T2D.com is a type-2-diabetes and prediabetes telehealth service that also sells compounded semaglutide or tirzepatide with its own prescriber for $170 a month all-in.

Compare the total cost of other GLP-1 programs and alternatives to T2D.com before deciding. A clinician should help you choose the right treatment.

Other programs to compare with T2D.com

These are partners: we may earn a commission if you sign up, at no cost to you.

  • RxSpan MDPartner

    Semaglutide modeled $249/mo · Tirzepatide modeled $329/mo

    RxSpan MD puts injections, oral capsules and three brand-name drugs on one account, with every price and plan length published; one month of the semaglutide injection is $249.

  • Sprout HealthPartner

    Semaglutide modeled $161.42/mo · Tirzepatide modeled $215.58/mo

    Sprout charges $149 every four weeks for compounded semaglutide and $199 for tirzepatide, or $99 and $149 a month if you prepay a full year.

  • OakPartner

    Semaglutide modeled $250/mo · Tirzepatide modeled $300/mo

    Oak's order form charges $250 a month for compounded semaglutide and $300 for tirzepatide at every dose, with no subscription and brand-name pens on the same menu, while its marketing pages advertise figures from $89 to $190 that the form does not offer.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to T2D.com's. See the alternatives to T2D.com.

Explore more provider reviews

Pricing, states and verification reflect T2D.com's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on T2D.com's site. Not medical advice; see our disclosure.

← Back to the value leaderboard